KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Intangibles (2018 - 2025)

Vir Biotechnology's Intangibles history spans 8 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Intangibles fell 3.33% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 3.33%, while the annual FY2025 figure was $7.8 million, 3.33% down from the prior year.
  • Intangibles for Q4 2025 was $7.8 million at Vir Biotechnology, down from $7.9 million in the prior quarter.
  • Across five years, Intangibles topped out at $33.7 million in Q1 2021 and bottomed at $7.8 million in Q4 2025.
  • The 5-year median for Intangibles is $25.5 million (2023), against an average of $23.6 million.
  • The largest annual shift saw Intangibles fell 1.54% in 2021 before it plummeted 64.07% in 2025.
  • A 5-year view of Intangibles shows it stood at $33.3 million in 2021, then decreased by 1.6% to $32.8 million in 2022, then plummeted by 31.11% to $22.6 million in 2023, then crashed by 64.02% to $8.1 million in 2024, then fell by 3.33% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Intangibles are $7.8 million (Q4 2025), $7.9 million (Q3 2025), and $8.0 million (Q2 2025).